Loading...
Guest User
Welcome! Please login.
| IPO Listing At | BSE SME |
| SME IPO Issue Type | Book Build Issue |
| Total Issue Size | ₹58.80 Cr |
| Reserved for Market Maker | ₹2.97 Cr |
| Net Issue Size | ₹58.80 Cr |
| Fresh Issue | ₹55.83 Cr |
| Face Value | ₹10 Per Equity Share |
| Price Band | ₹82.00-84.00 per share |
| BSE Code | 544460 |
| Registrar | MUFG Intime India Pvt.Ltd. |
| Lead Managers | Unistone Capital Pvt.Ltd. |
Disclaimer: GMP is sourced from grey market dealers and is indicative only. Always conduct your own due diligence.
* Allotment, Refund, Demat Credit & Listing dates are tentative and subject to change.
Minimum bid: 3,200 shares · Multiples of 1,600 shares
Incorporated in 2008, Patel Chem Specialities Limited (PCSL) is engaged in the manufacturing and exporting pharmaceutical excipients and specialty chemicals.
The company manufactures various essential chemicals used in pharmaceuticals, food, cosmetics, and industrial applications, serving as binders, disintegrants, thickeners, stabilizers, and gelling agents across industries.
The company’s manufacturing facilities in Vatva, Ahmedabad, and Talod, Himmatnagar, follow strict quality control standards, ensuring bulk production of chemicals that meet international certifications like US-DMF and GMP.
The company’s manufacturing facility covers 7,000 square yards, with a capacity of over 7,200 MT annually for pharmaceutical excipients, featuring departments for storage, production, R&D, quality control, packaging, and warehousing.
The company has expanded globally, serving East Asia, Europe, the Middle East, North America, and Southeast Asia, delivering high-quality products that meet international standards to lead the chemical industry.
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Funding capital expenditure requirement of the company | 43.15 |
| 2 | General Corporate Purposes | 8.40 |
| 3 | Issue Expenses | 7.25 |
| Total | 58.80 |
| Period Ended | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|
| Assets | 65.31 | 46.97 | 37.08 |
| Total Income | 105.55 | 82.72 | 69.75 |
| Profit After Tax | 10.57 | 7.66 | 2.89 |
| EBITDA | 15.80 | 12.02 | 5.83 |
| NET Worth | 35.40 | 19.52 | 11.87 |
| Reserves and Surplus | 17.53 | 18.52 | 10.87 |
| Total Borrowing | 14.85 | 15.46 | 11.79 |
| Amount in ₹ Crore | |||
| KPI | Mar 31, 2025 |
|---|---|
| ROE | 29.85% |
| ROCE | 36.26% |
| Debt / Equity | 0.42% |
| RoNW | 24.32% |
| PAT Margin | 10.01% |
| EBITDA Margin | 14.97% |
| Price to Book Value | 4.11 |
| Metric | Pre IPO | Post IPO |
|---|---|---|
| EPS (₹) | 5.91 | 4.25 |
| P/E (x) | 14.21 | 19.77 |
| Promoter Holding | 95.13% | 69.78% |
| Market Cap | ₹208.91 Cr. | |
